Druckansicht
 
 

Redefining Therapeutic Paradigms for Microtubule Inhibitors

Physicians Education Resource
Archiv
-
05.06.2010  Chicago
Not an official event of the ASCO Annual Meeting. Not sponsored or endorsed by ASCO or the ASCO Cancer Foundation.
 
Kursinhalte
Satellite symposium will highlight advances in the use of novel cytotoxic agents for the treatment of metastatic breast cancer (MBC), non–small-cell lung cancer (NSCLC), pancreatic cancer, and melanoma. Recent data indicate that novel taxane formulations and other microtubule-interacting agents might improve the therapeutic index in MBC and NSCLC. In addition, these agents are demonstrating activity in melanoma and pancreatic cancer, malignancies that have been resistant to traditional...
Lernziele, Trainingsziele
Please see our websie for all the details www.cancerlearning.com
Zielpublikum
medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer, NSCLC, pancreatic cancer, and melanoma. Fellows, nurse practitioners, nurses, physician assistants, practitioners, nurses, physician assistants
Anmerkungen
http://www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/548
 

Anfragen und Anmeldung:

Herr Duane Fowler
001 888 949 0045
 
Kategorien
Onkologie
Sprache
Englisch
Kosten
no registration fee
Veranstalter Kontakt
3500 Maple Ave. Ste. 700
75219 Dallas
USA
Tel: 001 888 949 0045
Fax: 001 314 367 3305
info@cancerlearning.com
 
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."

Charité International AcademyFFG - 7. EU-RahmenprogrammÖsterreichische Akademie der ÄrzteÖsterreichisches Rotes KreuzÄrztekammer für WienCenter of ExcellencenewTreeHelix - Forschung & Beratung Wien

Facebook